ACT Genomics is a series b startup. 2 investors tracked. Status: possibledead.
ACT Genomics is a startup based in Taiwan. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
ACT Genomics is a cancer solution provider. It offers a range of services including biomarker testing, drug development, and precision medicine.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.